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Abstract:
Aims: The purpose of this study is to present an overall informtion on the characteristics of 
patients living with pulmonary artery hypertension associated with congenital heart disease 
(PAH-CHD) and  the current management of this disease  in Vietnam.
Methos: This study inclued a cross- sectional restrospective study on 96 patients from April 
2014 to July 2015 and a cross- sectional prospective study on 121 patients from January 2016 
to July 2017 who were diagnosed PAH- CHD and treated in Vietnam National Heart Institute, 
the National Hospital Terminal of the North of Vietnam. Both incidence and prevalence cases 
were included. We not only reported the clinical and physiological chracteristics at the time 
of diagnosis for this cohort of patients but also described the management strategy of these 
patients in Vietnam.
Reults: A total of 217 patients were identifi ed as having PAH – CHD with 36 mean age, 73% 
female. The ASD was the most common pathologic classifi cation with 51%. At the time of 
enrollment, 19% of patients were diagnosed Eisenmenger. 6 MWD, proBNP, RA area, TAPSE 
usuaslly were used in assessments the severity and the risk of death of all PAH patients, there 
was 63% patients with low risk, 25% patients with intermediated risk and 11% patients with 
high risk, the death rate in hospital was 7.3% with the most common trigger was pregnancy. 
The high risks for pulmonary thromboembolism in ES group were described as hypervisocoity, 
NYHA IV, high CRP, large dilated pulmonary arteries, and dual ventricular dysfunction. In 
this cohort patients, we performed the corrective treatment for 28% patients, and the 72% 
remaining patients were treated with PAH specifi c therapy and would be reassessed after 3-6 
months duration. PGEi5 was the most mommonly used target therapy (36%) followed by the  
combination of ERA and PGiE5 (14%).
Conclusion: Our patients are detected at the advanced stage of the disease, and thus the 
mortality is still unacceptably high. The rate of the PAH patient group could not be completely 
corrective treatment was still high and we lacked of special procedure to correct the defects 
beside special PAH therapy .
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